Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Healthcare Medical Devices
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

Recent & Breaking News (TSXV:MIR)

MedMira Announces Product Update

GlobeNewswire December 30, 2020

MedMira Reports First Quarter Results FY2021

GlobeNewswire December 24, 2020

MedMira Reports FY2020 Fourth Quarter and Year End Financial Results

GlobeNewswire November 30, 2020

MedMira reports additional independent performance evaluation results of REVEALCOVID-19(TM) Total Antibody Test

GlobeNewswire October 7, 2020

REVEALCOVID-19(TM) Total Antibody Test Sensitivity and Cross-Reactivity Analysis

GlobeNewswire September 3, 2020

MedMira's July Update as per the IIROC Request

GlobeNewswire July 10, 2020

MedMira Reports Third Quarter Results FY2020

GlobeNewswire June 29, 2020

The Top Healthcare Bullboards: April - June 2020

Stockhouse Editorial June 17, 2020

IIROC Trading Resumption - MIR

Canada NewsWire May 27, 2020

MedMira Announces Exclusive Distribution Partnership with Webb Diagnostic Technologies and Initial Order for REVEALCOVID-19(TM) Total Antibody Test in the U.S.

GlobeNewswire May 27, 2020

IIROC Trading Halt - MIR

Canada NewsWire May 27, 2020

Webb Diagnostic Technologies to Market Rapid Total Antibody Test

PR Newswire April 23, 2020

MedMira Announces Notification Submission to US FDA Emergency Use Authorization

GlobeNewswire April 23, 2020

IIROC Trading Resumption - MIR

Canada NewsWire April 16, 2020

MedMira Announces Update on Development of Point-of-Care Antibody Test

GlobeNewswire April 15, 2020

IIROC Trading Halt - MIR

Canada NewsWire April 15, 2020

MedMira Reports Second Quarter Results FY2020

GlobeNewswire March 31, 2020

MedMira Reports First Quarter Results FY2020

GlobeNewswire December 30, 2019

MedMira Reports 2019 Fourth Quarter and Year End Financial Results

GlobeNewswire November 28, 2019

MedMira Reports Third Quarter Results

GlobeNewswire June 28, 2019